<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE trials [
<!ELEMENT trials (trial+)>

<!ELEMENT trial (main,contacts,countries,criteria,health_condition_code,health_condition_keyword,intervention_code,
          intervention_keyword,primary_outcome,secondary_outcome,secondary_sponsor,secondary_ids,source_support,ethics_reviews)>

<!ELEMENT main (trial_id,utrn?,reg_name,date_registration,primary_sponsor,public_title,acronym?,scientific_title,scientific_acronym?,
          date_enrolment,type_enrolment,target_size,recruitment_status,url?,study_type,study_design,phase,hc_freetext?,i_freetext?,results_actual_enrolment,results_date_completed,results_url_link,results_summary,           results_date_posted,results_date_first_publication,results_baseline_char,results_participant_flow,results_adverse_events,results_outcome_measures,results_url_protocol,results_IPD_plan, results_IPD_description)>
<!ELEMENT trial_id (#PCDATA)>
<!ELEMENT utrn (#PCDATA)>
<!ELEMENT reg_name (#PCDATA)>
<!ELEMENT date_registration (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT primary_sponsor (#PCDATA)>
<!ELEMENT public_title (#PCDATA)>
<!ELEMENT acronym (#PCDATA)>
<!ELEMENT scientific_title (#PCDATA)>
<!ELEMENT scientific_acronym (#PCDATA)>
<!ELEMENT date_enrolment (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT type_enrolment (#PCDATA)>
<!ELEMENT target_size (#PCDATA)>
<!ELEMENT recruitment_status (#PCDATA)><!-- Pending,Recruiting,Suspended,Complete,Other -->
<!ELEMENT url (#PCDATA)>
<!ELEMENT study_type (#PCDATA)><!-- interventional,observational -->
<!ELEMENT study_design (#PCDATA)>
<!ELEMENT phase (#PCDATA)>
<!ELEMENT hc_freetext (#PCDATA)>
<!ELEMENT i_freetext (#PCDATA)>
<!ELEMENT results_actual_enrolment (#PCDATA)>
<!ELEMENT results_date_completed (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_url_link (#PCDATA)>
<!ELEMENT results_summary (#PCDATA)>
<!ELEMENT results_date_posted (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_date_first_publication (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_baseline_char (#PCDATA)>
<!ELEMENT results_participant_flow (#PCDATA)>
<!ELEMENT results_adverse_events (#PCDATA)>
<!ELEMENT results_outcome_measures (#PCDATA)>
<!ELEMENT results_url_protocol (#PCDATA)>
<!ELEMENT results_IPD_plan (#PCDATA)>
<!ELEMENT results_IPD_description (#PCDATA)>


<!ELEMENT contacts (contact+)>
<!ELEMENT contact (type,firstname,middlename,lastname,address,city,country1,zip,telephone,email,affiliation)>
<!ELEMENT type (#PCDATA)><!-- Public,Scientific -->
<!ELEMENT firstname (#PCDATA)>
<!ELEMENT middlename (#PCDATA)>
<!ELEMENT lastname (#PCDATA)>
<!ELEMENT address (#PCDATA)>
<!ELEMENT city (#PCDATA)>
<!ELEMENT country1 (#PCDATA)>
<!ELEMENT zip (#PCDATA)>
<!ELEMENT telephone (#PCDATA)>
<!ELEMENT email (#PCDATA)>
<!ELEMENT affiliation (#PCDATA)>

<!ELEMENT countries (country2+)>
<!ELEMENT country2 (#PCDATA)>

<!ELEMENT criteria (inclusion_criteria,agemin,agemax,gender,exclusion_criteria)>
<!ELEMENT inclusion_criteria (#PCDATA)>
<!ELEMENT agemin (#PCDATA)>
<!ELEMENT agemax (#PCDATA)>
<!ELEMENT gender (#PCDATA)>
<!ELEMENT exclusion_criteria (#PCDATA)>

<!ELEMENT health_condition_code (hc_code+)>
<!ELEMENT hc_code (#PCDATA)>

<!ELEMENT health_condition_keyword (hc_keyword+)>
<!ELEMENT hc_keyword (#PCDATA)>

<!ELEMENT intervention_code (i_code+)>
<!ELEMENT i_code (#PCDATA)>

<!ELEMENT intervention_keyword (i_keyword+)>
<!ELEMENT i_keyword (#PCDATA)>

<!ELEMENT primary_outcome (prim_outcome+)>
<!ELEMENT prim_outcome (#PCDATA)>

<!ELEMENT secondary_outcome (sec_outcome+)>
<!ELEMENT sec_outcome (#PCDATA)>

<!ELEMENT secondary_sponsor (sponsor_name+)>
<!ELEMENT sponsor_name (#PCDATA)>

<!ELEMENT secondary_ids (secondary_id+)>
<!ELEMENT secondary_id (sec_id,issuing_authority)>
<!ELEMENT sec_id (#PCDATA)>
<!ELEMENT issuing_authority (#PCDATA)>

<!ELEMENT source_support (source_name+)>
<!ELEMENT source_name (#PCDATA)>

<!ELEMENT ethics_reviews (ethics_review+)>
<!ELEMENT ethics_review (status,approval_date,contact_name,contact_address,contact_phone,contact_email)>
<!ELEMENT status (#PCDATA)><!-- Not approved,Approved,NA -->
<!ELEMENT approval_date (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT contact_name (#PCDATA)>
<!ELEMENT contact_address (#PCDATA)>
<!ELEMENT contact_phone (#PCDATA)>
<!ELEMENT contact_email (#PCDATA)>
]>
<trials>
  <trial>
    <main>
      <trial_id>IRCT20231128060213N1</trial_id>
      <utrn></utrn>
      <reg_name>IRCT</reg_name>
      <date_registration>2024-01-05</date_registration>
      <primary_sponsor>Islamic Azad University</primary_sponsor>
      <public_title>Investigating the effect of cognitive behavioral therapy on patients with generalized anxiety disorder.</public_title>
      <acronym></acronym>
      <scientific_title>The Effectiveness of Metacognitive Therapy on Believability of Anxious Feeling and Thought, Emotional Distress Tolerance and Medication Adherence in Patients with Generalized Anxiety Disorder</scientific_title>
      <scientific_acronym></scientific_acronym>
      <date_enrolment>2023-11-15</date_enrolment>
      <type_enrolment>anticipated</type_enrolment>
      <target_size>32</target_size>
      <recruitment_status>Complete</recruitment_status>
      <url>https://irct.ir/trial/74037</url>
      <study_type>interventional</study_type>
      <study_design>Randomization: Randomized, Blinding: Not blinded, Placebo: Not used, Assignment: Parallel, Purpose: Treatment, Randomization description: In this study, 32 people are selected using GPOWER software in an accessible way. Then random replacement is done by lottery method (one number is assigned to each sample). We write down the numbers on the paper, fold them and put them in the container. We mix and stir the papers completely. Then we take out the papers one by one and put one number in the first group and one number in the second group. Then random application will be done. In this way, one group is known as "control group" and the other group is known as "intervention group". The lottery will be done by putting the two groups obtained from the previous step (random replacement step) into two separate envelopes and placing them in a container. Then we randomly take out an envelope that contains 16 numbers from the container and assign it to the "intervention group" and the other envelope that also contains 16 numbers to the "control group". Finally, the intervention group: receive 8 sessions of 120 minutes of metacognitive therapy for generalized anxiety of Wells, and the second group, as a control group, does not receive any psychological treatment.</study_design>
      <phase>N/A</phase>
      <hc_freetext>Patients with Generalized Anxiety Disorder.</hc_freetext>
      <i_freetext>Intervention 1: Intervention group: In this study, there is an experimental group and a control group. Before the intervention, research participants will undergo pre-tests of credible beliefs and anxiety-related variables, emotional distress tolerance, and medication adherence. After this stage, participants in the experimental group will receive 8 sessions of 120-minute cognitive-behavioral therapy for generalized anxiety, while the control group will not receive any training. Subsequently, participants from both the experimental and control groups will undergo post-tests. The content of the sessions is as follows: 1. Pre-test execution, preparation, and introduction to cognitive-behavioral therapy, presentation of cognitive-behavioral therapy rationale. 2. Familiarization with cognitive attention syndrome and its impact on the continuity of mental disorders, questioning about the effectiveness of self-regulatory behaviors (coping), suppression of thoughts experiment. 3. Challenging negative cognitive beliefs related to uncontrollable thoughts, negative thoughts, and emotions, teaching independent mindfulness exercises, independent mindfulness exercises about neutral thoughts. 4. Continued challenge with uncontrollability beliefs (examining opposing evidence), delaying thoughts experiment, loss of control experiment in therapy session. 5. Challenging positive cognitive beliefs related to uncontrollability of danger and harm, introduction to verbal methods and behavioral experiments. 6. Challenging positive cognitive beliefs, presenting non-matching and inconsistency strategies, modifying cognitive thought experiments. 7. Presentation of a new processing plan including: identifying the process of thoughts-anxieties-stresses-emotions and worries, emphasizing the use of independent attention for triggering thoughts, allowing emotions and thoughts to peak and subside without effort to control them, repeated execution of new thinking styles. 8. Monitoring progress, presenting a summary of techniques presented in all therapy sessions, answering questions and problems in using these techniques, getting feedback from all sessions, conducting post-tests. Intervention 2: Control group: The control group will undergo pre-tests and post-tests for variables such as belief in thoughts and anxiety, tolerance of emotional distress, and adherence to medication, and will not receive cognitive-behavioral therapy intervention.</i_freetext>
      <results_actual_enrolment></results_actual_enrolment>
      <results_date_completed></results_date_completed>
      <results_url_link></results_url_link>
      <results_summary></results_summary>
      <results_date_posted></results_date_posted>
      <results_date_first_publication></results_date_first_publication>
      <results_baseline_char></results_baseline_char>
      <results_participant_flow></results_participant_flow>
      <results_adverse_events></results_adverse_events>
      <results_outcome_measures></results_outcome_measures>
      <results_url_protocol></results_url_protocol>
      <results_IPD_plan>Yes - There is a plan to make this available</results_IPD_plan>
      <results_IPD_description>What will be shared:
The main results will be shared after the end of the study.

When:
6 months

To whom:
Upon request, the study results will be made available to other academic researchers

Conditions:
The collected data is confidential and will not be shared with others

Where to obtain:
To receive documents, send an email to the person responsible for updating

How to obtain:
Within 15 days, the documents will be sent by email

Comments:
</results_IPD_description>
    </main>
    <contacts>
      <contact>
        <type>public</type>
        <firstname>Ghodratollah Abbasi</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>5th floor Humanities Building, Azad University , Farah Abad Road, Khazar Square</address>
        <city>Sari</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>4816119318</zip>
        <telephone>+98 11 3303 2891</telephone>
        <email>gh_abbasi@iausari.ac.ir</email>
        <affiliation>Islamic Azad University</affiliation>
      </contact>
      <contact>
        <type>scientific</type>
        <firstname>Ghodratollah Abbasi</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>5th floor Humanities Building, Azad University , Farah Abad Road, Khazar Square</address>
        <city>Sari</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>4816119318</zip>
        <telephone>+98 11 3303 2891</telephone>
        <email>gh_abbasi@iausari.ac.ir</email>
        <affiliation>Islamic Azad University</affiliation>
      </contact>
    </contacts>
    <countries>
      <country2>Iran (Islamic Republic of)</country2>
    </countries>
    <criteria>
      <inclusion_criteria>Having informed consent and the ability to participate in therapy sessions
Having generalized anxiety disorder (scoring above the cutoff point on the Generalized Anxiety Disorder 7-item scale (GAD-7) and initial clinical interview)
Having literacy in reading and writing
Being aged 18 to 50
Needing medication treatment.</inclusion_criteria>
      <agemin>18 years</agemin>
      <agemax>50 years</agemax>
      <gender>Both</gender>
      <exclusion_criteria>Individuals with a history of psychiatric symptoms and psychosis diagnosed by a psychiatrist
history of hospitalization in a neurology and psychiatry hospital
Simultaneous use of alcohol and substance abuse disorder
Major psychiatric disorders such as major depressive disorder, bipolar disorder, and major cognitive disorders
Suffering from a significant physical illness
Participating in psychotherapy sessions simultaneously.</exclusion_criteria>
    </criteria>
    <health_condition_code>
      <hc_code>F41.1</hc_code>
    </health_condition_code>
    <health_condition_keyword>
      <hc_keyword>Generalized anxiety disorder</hc_keyword>
    </health_condition_keyword>
    <intervention_code>
      <i_code>Behavior</i_code>
      <i_code>Behavior</i_code>
    </intervention_code>
    <intervention_keyword>
      <i_keyword>Intervention group: In this study, there is an experimental group and a control group. Before the intervention, research participants will undergo pre-tests of credible beliefs and anxiety-related variables, emotional distress tolerance, and medication adherence. After this stage, participants in the experimental group will receive 8 sessions of 120-minute cognitive-behavioral therapy for generalized anxiety, while the control group will not receive any training. Subsequently, participants from both the experimental and control groups will undergo post-tests. The content of the sessions is as follows: 1. Pre-test execution, preparation, and introduction to cognitive-behavioral therapy, presentation of cognitive-behavioral therapy rationale. 2. Familiarization with cognitive attention syndrome and its impact on the continuity of mental disorders, questioning about the effectiveness of self-regulatory behaviors (coping), suppression of thoughts experiment. 3. Challenging negative cognitive beliefs related to uncontrollable thoughts, negative thoughts, and emotions, teaching independent mindfulness exercises, independent mindfulness exercises about neutral thoughts. 4. Continued challenge with uncontrollability beliefs (examining opposing evidence), delaying thoughts experiment, loss of control experiment in therapy session. 5. Challenging positive cognitive beliefs related to uncontrollability of danger and harm, introduction to verbal methods and behavioral experiments. 6. Challenging positive cognitive beliefs, presenting non-matching and inconsistency strategies, modifying cognitive thought experiments. 7. Presentation of a new processing plan including: identifying the process of thoughts-anxieties-stresses-emotions and worries, emphasizing the use of independent attention for triggering thoughts, allowing emotions and thoughts to peak and subside without effort to control them, repeated execution of new thinking styles. 8. Monitoring progress, presenting a summary of techniques presented in all therapy sessions, answering questions and problems in using these techniques, getting feedback from all sessions, conducting post-tests.</i_keyword>
      <i_keyword>Control group: The control group will undergo pre-tests and post-tests for variables such as belief in thoughts and anxiety, tolerance of emotional distress, and adherence to medication, and will not receive cognitive-behavioral therapy intervention.</i_keyword>
    </intervention_keyword>
    <primary_outcome>
      <prim_outcome>Believability of Anxious Feeling and Thought. Timepoint: Before the study and immediately after the intervention. Method of measurement: questionnaire Believability of Anxious Feeling and Thought.</prim_outcome>
      <prim_outcome>Emotional Distress Tolerance. Timepoint: Before the study and immediately after the intervention. Method of measurement: questionnaire Emotional Distress Tolerance.</prim_outcome>
      <prim_outcome>Medication Adherence. Timepoint: Before the study and immediately after the intervention. Method of measurement: questionnaire Medication Adherence.</prim_outcome>
    </primary_outcome>
    <secondary_outcome>
      <sec_outcome></sec_outcome>
    </secondary_outcome>
    <secondary_sponsor>
      <sponsor_name></sponsor_name>
    </secondary_sponsor>
    <secondary_ids>
      <secondary_id>
        <sec_id></sec_id>
        <issuing_authority></issuing_authority>
      </secondary_id>
    </secondary_ids>
    <source_support>
      <source_name>Islamic Azad University</source_name>
    </source_support>
    <ethics_reviews>
      <ethics_review>
        <status>Approved</status>
        <approval_date>2023-11-14</approval_date>
        <contact_name>Ethics committee of Islamic Azad University - Sari branch</contact_name>
        <contact_address>5th floor, Medical Building, Azad University, Farah Abad Road, Khazar Square ,Sari. Sari Mazandaran Iran (Islamic Republic of)</contact_address>
        <contact_phone></contact_phone>
        <contact_email></contact_email>
      </ethics_review>
    </ethics_reviews>
  </trial>
</trials>
